Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| NSA, Inc | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The proposed study will test the following hypotheses:
In general antioxidant status appears to influence wound healing in humans and in animal models of acute trauma, with low antioxidant concentrations and excessive oxidative stress being associated with impaired healing. Whilst antioxidant supplementation has been reported to improve plasma antioxidant status and wound healing in animal models of acute trauma, there is remarkably little data from human studies.
The use of Juice Plus+ has been reported to increase serum concentrations of important antioxidants and reduce serum markers of oxidative stress. However, to date there are no reported studies concerning the potential for Juice Plus+ to improve patient-based outcome measures following the surgical removal of lower third molars. This study therefore proposes to investigate the impact of daily supplementation with Juice Plus+, in improving outcomes following surgical trauma. While the rationale for the proposed study is primarily predicated on the established role of oxidative stress and antioxidant micronutrients in chronic inflammatory diseases, the proposed randomized controlled clinical study represents an efficient way of evaluating the potential for adjunctive Juice Plus+ use in improving wound healing and reducing post-operative morbidity following surgical procedures on humans.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Juice Plus | Experimental |
| |
| Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Juice plus | Dietary Supplement | Juice Plus (2 capsules bds) for 11 weeks (10 weeks preop and 1 week postop) |
|
| Measure | Description | Time Frame |
|---|---|---|
| Quality of Life | QOL as assessed by PoSSe scale (Ruta et al., 2000) | first postoperative week |
| Measure | Description | Time Frame |
|---|---|---|
| trismus | trismus will be assessed by investigator at 48h and 1 week postoperative, and every postop day by patient | postoperative week |
| postoperative pain | pain will be assessed by patient on VAS on each postop day. groups will be compared for the following:
|
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Thomas Dietrich, DMD, MD, MPH | University of Birmingham | Principal Investigator |
| Iain Chapple, BDS, PhD | Unversity of Birmingham | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Birmingham | Birmingham | West Midlands | B18 4DA | United Kingdom |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 28866140 | Derived | Gorecki P, Burke DL, Chapple ILC, Hemming K, Saund D, Pearson D, Stahl W, Lello R, Dietrich T. Perioperative supplementation with a fruit and vegetable juice powder concentrate and postsurgical morbidity: A double-blind, randomised, placebo-controlled clinical trial. Clin Nutr. 2018 Oct;37(5):1448-1455. doi: 10.1016/j.clnu.2017.08.004. Epub 2017 Aug 10. |
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D014947 | Wounds and Injuries |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| postoperative week |
| analgesic use | first postoperative week |
| plasma total antioxidant capacity (TAOC) | group differences between plasma TAOC changes between baseline and 1 week postop | baseline (preop) and 1 week postop |
| serum biomarkers of oxidative stress | differences in change from baseline to 1 week of mean protein carbonyls, isoprostanes and 8OHdG | first postoperative week (baseline and 1 week) |
| serum concentration of acute phase reactants | change between baseline and 1 week of: CRP, fibrinogen, WBC | first postoperative week |
| adverse events | first postoperative week |